Market revenue in 2023 | USD 805.9 million |
Market revenue in 2030 | USD 1,392.1 million |
Growth rate | 8.1% (CAGR from 2023 to 2030) |
Largest segment | Logistics & distribution |
Fastest growing segment | Logistics & distribution |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Logistics & distribution, Storage & retention, Packaging, labeling and blinding, Manufacturing, Comparator sourcing, Other services (solutions, ancillary supply) |
Key market players worldwide | Thermo Fisher Scientific Inc, Catalent Inc, PAREXEL, Almac Group, Piramal Pharma Solutions, DHL Group, FedEx Corp, UDG Healthcare, Marken, Walden Group, PCI Pharma Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial supply & logistics market will help companies and investors design strategic landscapes.
Logistics & distribution was the largest segment with a revenue share of 25.34% in 2023. Horizon Databook has segmented the Asia Pacific clinical trial supply & logistics market based on logistics & distribution, storage & retention, packaging, labeling and blinding, manufacturing, comparator sourcing, other services (solutions, ancillary supply) covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is expected to be one of the fastest-growing regions in global clinical trial supply and logistics market. Significant growth in clinical research is expected to drive growth of clinical trial supplies market in the region, thereby contributing to growth of global clinical trial supply and logistics market.
According to a survey by Pharma IQ, 60.0% of the respondents consider China and India as potential regions for clinical research in the next five years. Entry of Almac Group, a global clinical research and manufacturing organization, in Asia Pacific region is a clear indication of growth of clinical trial supply and logistics market in this region.
Shift of clinical trial sites from Western regions such as North America and Europe is a major driver for entry of global clinical supplies players in this region. The trend is expected to continue and is anticipated to drive growth of clinical trial supply and logistics market in the region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific clinical trial supply & logistics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific clinical trial supply & logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account